The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
The introduction of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of hematological diseases, particularly in combating blood cancer. The success of this cell therapy approach has led to the development of approximately seven commercial CAR-T based drugs. However, th...
Saved in:
| Main Authors: | M. R. Khaliulin, R. N. Safin, M. A. Kunst, E. R. Bulatov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-04-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/647 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
by: A. А. Pavlova, et al.
Published: (2017-04-01) -
Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
by: Yang Liu, et al.
Published: (2025-05-01) -
Preparation of Trop2-targeted chimeric antigen receptor T cells and study of their exhaustion status in vitro
by: LIU Xiuying, et al.
Published: (2025-08-01) -
Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies
by: Xiaoshuang Yuan, et al.
Published: (2025-05-01) -
Dap10 co-stimulation enhances the anti-HCC efficacy of NKp30 chimeric antigen receptor T cells
by: JieYu Li, et al.
Published: (2025-07-01)